Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream

Inclusion Criteria: * Normal or clinically insignificant dermatological history the Screening visit and Day 1dosing; Exclusion Criteria: * Female subjects who were pregnant, nursing, or planning to become pregnant during study participation; * History of hypersensitivity to the study products or any topical or systemic corticosteroids;